Basic Thorazine Information

• INN (International Nonproprietary Name): Chlorpromazine.
• Brand Names Available In United States: Thorazine, Ormazine, Thorazine Spansule; tablets (10 mg, 25 mg, 50 mg, 100 mg, 200 mg) and injectable solution (25 mg/mL).
• ATC Code: N05AA01 (Phenothiazines with aliphatic side-chain; chlorpromazine).
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg, 100 mg, 200 mg; oral solution commonly 10 mg/mL; injection (IM/IV) commonly 25 mg/mL.
• Manufacturers In United States: Supplied by Sandoz and multiple generic manufacturers; often marketed as Thorazine/Ormazine or generic chlorpromazine hydrochloride.
• Registration Status In United States: FDA-approved prescription drug for multiple indications and listed on the WHO Model List of Essential Medicines.
• OTC / Rx Classification: Prescription-only (Rx) in all jurisdictions.

Everyday Use & Best Practices

Worried about when to take Thorazine or how it will affect your day-to-day life?

Morning Vs Evening Dosing

Follow your prescriber’s plan for thorazine dosing and timing unless they advise otherwise.

Many regimens split the total daily chlorpromazine dosage into two to four doses for steadier blood levels.

Starting doses for psychosis commonly begin at 25–100 mg three times daily, titrated based on response and tolerability.

Maintenance therapy most often ranges from 200–800 mg per day divided into multiple doses, adjusted to the lowest effective dose.

If daytime sedation is a problem, ask the clinician about shifting larger doses to the evening or taking a stronger bedtime dose to reduce daytime drowsiness.

Elderly patients typically start at about half the usual adult dose and clinicians often prefer evening dosing when sedative effects are prominent.

Use this checklist to decide when to contact your prescriber about dose timing:

• Excessive daytime sleepiness that interferes with work or safety.
• Orthostatic dizziness or frequent near-fainting when standing.
• Breakthrough symptoms of agitation, hallucinations, or severe nausea despite current dosing.

Taking With Or Without Meals

Thorazine (chlorpromazine) can be taken with food to reduce stomach upset and nausea.

If nausea occurs after a dose, taking chlorpromazine tablets or solution with a snack or meal often helps.

Avoid alcohol while taking Thorazine because it increases CNS depression and sedation risk.

• Take Thorazine at the same times each day to keep steady blood levels.
• Be consistent about whether you take doses with or without food to reduce variability.
• Avoid abrupt dose changes without medical guidance.

Safety Priorities

Who should not take chlorpromazine and which activities should be limited while on treatment?

Who Should Avoid It

Absolute contraindications to chlorpromazine include comatose states or significant central nervous system depression.

Known hypersensitivity to phenothiazines or chlorpromazine is an absolute contraindication.

Severe bone marrow depression and pheochromocytoma are absolute contraindications.

Children under six months should not receive chlorpromazine.

Relative caution is required for people with hepatic or renal impairment, cardiovascular disease—especially QT prolongation—history of seizures, Parkinson’s disease, dementia, and the elderly.

Before starting thorazine, disclose all medications, cardiac history, liver disease, low white blood cell counts, and pregnancy status to your prescriber and pharmacist.

Activities To Limit

Until you know how chlorpromazine affects you, avoid driving or operating heavy machinery because drowsiness and blurred vision may occur.

Limit alcohol and other central nervous system depressants, including opioids and benzodiazepines, because these increase sedation and respiratory depression risk.

Be cautious in hot environments as photosensitivity and impaired temperature regulation can occur with Thorazine.

• Do not drive until you know how thorazine affects your alertness.
• Do not mix chlorpromazine with alcohol or other sedating substances unless directed by a clinician.
• Avoid sudden standing; get up slowly to reduce orthostatic hypotension risk.

Dosage & Adjustments

How is chlorpromazine dosed for different needs, and when do clinicians lower doses?

General Regimen

For psychosis, adults often start with 25–100 mg three times daily and the dose is titrated to effect and tolerability.

Typical maintenance dosing ranges from 200–800 mg per day divided into two to four doses based on clinical response.

For nausea or vomiting, smaller oral doses such as 10–25 mg every 4–6 hours are commonly used.

For preoperative anxiety, a single dose of 25–50 mg about one hour before the procedure is typical.

Chlorpromazine tablets are available in 10, 25, 50, 100, and 200 mg strengths, and injectable solution is commonly 25 mg/mL.

Special Cases

Children receive weight-based dosing for severe behavioral issues: about 0.5–0.55 mg/kg per dose every 4–6 hours, with cautious titration.

Elderly patients should begin at about half the adult dose and be monitored closely for falls, orthostatic hypotension, and sedation.

Patients with renal or hepatic impairment require dose reductions and close monitoring because of the risk of accumulation and enhanced central nervous system effects.

• Triggers for dose reduction include age over 65, hepatic or renal impairment, and severe sedation interfering with daily function.
• Adjust slowly and reassess frequently when changing doses in special populations.

User Testimonials

What real people report about Thorazine in emergency and outpatient use.

Positive Reports

Many patients report a rapid reduction in acute agitation and psychosis when chlorpromazine is used appropriately in emergency settings.

Injectable chlorpromazine (25 mg/mL) often produces fast calming when oral intake is not possible.

Lower doses are reported to control severe nausea in many cases.

Short anonymized quotes patients have shared include:

• "Helped my agitation within hours."
• "Stopped my severe nausea when nothing else worked."
• "Felt drowsy but finally slept after a few days on chlorpromazine."

Common Challenges

Common side effects reported by patients include daytime drowsiness, dry mouth, constipation, and orthostatic dizziness.

Some patients describe extrapyramidal symptoms such as tremor or akathisia early in treatment.

Long-term risks like tardive dyskinesia and rare but serious neuroleptic malignant syndrome are important to monitor.

Buying Guide

Where Thorazine and chlorpromazine can be obtained and how to compare prices.

Pharmacy Sources

Thorazine (brand) and chlorpromazine generics are prescription-only by regulation, and in the United States Thorazine and Ormazine are supplied by Sandoz and other manufacturers.

Pharmacies commonly stock tablets in 10–200 mg strengths, oral solutions commonly 10 mg/mL, and injectable vials at 25 mg/mL.

For continuity of care, using a single pharmacy helps track refills, interactions, and prior authorizations.

In our online pharmacy, thorazine is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

What’s Inside & How It Works

What chlorpromazine formulations contain and the basic pharmacology behind Thorazine’s effects.

Ingredients Overview

The active ingredient is chlorpromazine (INN), typically as chlorpromazine hydrochloride in pharmaceutical products.

Available formulations include tablets (10–200 mg), oral solution (often 10 mg/mL), and injection (25 mg/mL).

Excipients vary by manufacturer—check the package insert for specific inactive ingredients if you have allergies.

Thorazine is manufactured globally by generics and legacy brands; in the US it is supplied under Thorazine and Ormazine names and as generic chlorpromazine.

Mechanism Basics

Chlorpromazine is a first-generation antipsychotic in the phenothiazine class (ATC N05AA01) that antagonizes dopamine D2 receptors.

It also affects serotonin and histamine receptors, which contributes to antipsychotic, antiemetic, sedative, and hypotensive effects.

Main Indications

When clinicians commonly prescribe chlorpromazine and typical dosing examples.

Approved Uses

• Schizophrenia and other psychoses — typical start 25–100 mg three times daily with maintenance 200–800 mg/day divided.
• Severe behavioral disturbance — dosing follows psychosis protocols and clinical judgment.
• Nausea and vomiting — lower doses such as 10–25 mg every 4–6 hours are used.
• Bipolar mania — dosing similar to schizophrenia regimens when indicated.
• Preoperative anxiety — 25–50 mg about one hour before procedures.
• Injectable chlorpromazine is a standard option for acute agitation when oral dosing is not feasible.

Off-Label Uses

Off-label or situational uses include persistent hiccups, adjunctive sedation in palliative care, and refractory nausea in select cases.

Off-label use should be clinician-directed with informed consent and careful monitoring for adverse effects.

• Confirm the indication and document informed consent for off-label uses.
• Monitor closely for extrapyramidal symptoms and other adverse reactions.

Interaction Warnings

Food and drug interactions that matter for safety when taking Thorazine.

Food Interactions

There are no major food interactions with chlorpromazine documented in the product information, and taking thorazine with food can reduce gastrointestinal upset.

Avoid alcohol while taking chlorpromazine because of increased sedation and respiratory depression risk.

Photosensitivity is a known effect; avoid excessive sun exposure and use sunscreen and protective clothing.

Drug Conflicts

Latest Evidence & Insights

Summary of where chlorpromazine stands in modern practice and what recent studies emphasize.

Recent Studies

Recent literature highlights chlorpromazine’s historic role as the first antipsychotic and its continued utility in acute settings for rapid tranquilization and antiemetic effects.

Comparative studies generally favor newer atypical antipsychotics for long-term use because they carry lower risks of tardive dyskinesia and different metabolic profiles.

Chlorpromazine remains effective and cost-accessible, and its inclusion on the WHO Model List of Essential Medicines reflects continued global utility in low-resource settings.

Practical Implications

Clinicians should weigh efficacy, side-effect profiles, and cost when choosing chlorpromazine versus atypical antipsychotics.

Consider chlorpromazine for acute parenteral control when rapid tranquilization is needed or when generics reduce cost barriers to treatment access.

• Assess the indication carefully and review cardiac, hepatic, and neurological risks before starting.
• Choose the formulation that matches the clinical setting: injectable for emergency use, oral tablets or solution for outpatient care.
• Set a monitoring plan for movement disorders, metabolic effects for long-term therapy, and ECG monitoring if cardiac risk factors are present.

Alternative Choices

When Thorazine may not be the best fit and what other options exist.

Comparable Drugs

Other typical antipsychotics used for acute agitation include haloperidol, fluphenazine, and perphenazine.

Atypical antipsychotics such as risperidone, olanzapine, quetiapine, and clozapine may be preferred for long-term therapy because of different side-effect profiles.

Selection should consider propensity for extrapyramidal symptoms versus metabolic syndrome, speed of onset, availability of injectables, and cost.

Non-Drug Options

Nonpharmacologic measures should be first-line for agitation or anxiety when safe and feasible, including verbal de-escalation, environment modification, and behavioral strategies.

For nausea, hydration, dietary adjustments, and antiemetics with lower CNS effects may be suitable alternatives.

Regulation Snapshot

Quick regulatory facts clinicians and patients often ask about Thorazine availability.

FDA/WHO Status

Chlorpromazine (INN) is FDA-approved in the United States for multiple indications and is listed on the WHO Model List of Essential Medicines.

Brand names and packaging vary by country: Thorazine and Ormazine in the US, Largactil in the UK/Europe, and many generics worldwide.

The drug is prescription-only in all jurisdictions.

Prescription Rules

Chlorpromazine requires a prescription for outpatient use; injectable administration in hospitals follows facility protocols for monitoring and documentation.

• Prescribers should verify the indication and review contraindications before initiating therapy.
• Counsel patients on side effects and activity limitations.
• Document informed consent for any off-label uses.

FAQ Section

Short answers to common patient questions about Thorazine.

Quick Answers

• Can I stop suddenly? No — do not abruptly stop chlorpromazine without consulting your prescriber because withdrawal or symptom recurrence can occur.
• Is it safe in pregnancy? Discuss with your clinician; risks versus benefits must be weighed and individualized.
• How to handle missed doses? Take the missed dose when remembered unless it is close to the next dose; do not double up.
• What about driving? Avoid driving until you know how thorazine affects your alertness and coordination.

When To Call Your Doctor

Seek urgent medical care for high fever, muscle rigidity, severe tremor, confusion, sudden shortness of breath, chest pain, signs of infection such as sore throat or mouth ulcers, fainting, or irregular heartbeat.

These symptoms may indicate neuroleptic malignant syndrome, agranulocytosis, or cardiac events and require immediate attention.

Non-urgent issues to report include progressive daytime sedation, persistent constipation, and new movement symptoms for dose review and management.

Guidelines For Proper Use

How clinicians and patients should monitor therapy and how to store and dispose of chlorpromazine safely.

Monitoring And Follow-Up

Baseline assessments before starting chlorpromazine should include medical history focused on cardiac disease, liver function, seizure history, current medications, pregnancy status, and baseline vital signs.

Monitor weight, blood pressure including orthostatic checks, extrapyramidal symptoms, and mental state periodically after initiation and after dose changes.

For long-term use, assess for tardive dyskinesia and consider periodic blood work if clinically indicated.

Schedule follow-up within one to four weeks after starting or changing doses; monitor more frequently for elderly patients or those with hepatic/renal impairment or interacting medications.

Storage & Disposal

Store chlorpromazine at room temperature between 20–25°C and protect tablets and oral solutions from moisture and light.

Do not freeze injectable ampoules; inspect injectable vials or ampoules for particulates before use.

• Keep medication out of reach of children.
• Dispose of unused tablets or solutions via local pharmacy take-back programs when available.
• If no take-back program exists, follow local regulations for safe pharmaceutical disposal.

Delivery Across United States